[ET Net News Agency, 8 November 2021] GENSCRIPT BIO (01548) fell 9.98% to HK$27.05.
It hits an intra-day low of HK$26.9, and an intra-day high of HK$30.1. The total shares
traded was 2.9 million, with a value of HK$81.74m. The active buy/sell ratio is 39:61,
with net selling turnover of HK$17.25m. CHINA INV INFO accounts for greatest net
responsive buying turnover of HK$6.91m, with volume weighted average price of HK$28.169.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$13.65m,
with volume weighted average price of HK$28.222. The stock has fallen a combined 11.17%
over the past 2 consecutive trading days.
The Hang Seng Index now fell 144 points, or 0.58% to 24,725; the Hang Seng China
Enterprises Index now fell 41 points, or 0.47% to 8,779; the Hang Seng TECH Index now fell
79 points, or 1.27% to 6,196; with an overall turnover of HK$23.17b.
The SSE Composite Index now rose 5 points, or 0.16% to 3,497, with an overall turnover
of RMB110.34b.
The SZSE Component Index now rose 3 points, or 0.03% to 14,466, with an overall turnover
of RMB75.32b.
Basic Information
=================
---------------------------------
Nominal 27.050 % Chg -9.98%
High 30.100 Low 26.900
Shares Tr 2.9m Turnover 81.74m
10-D SMA 31.435 %H.V 85.894
20-D SMA 31.027 VWAP 28.204
50-D SMA 32.589 RSI14 37.953
---------------------------------
Status: Active buy/sell ratio is 39:61, with net selling turnover of HK$17.25m, falling a
combined 11.17% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
GENSCRIPT BIO (01548) 27.05 -9.98
INNOVENT BIO (01801) 69.00 Unchanged
JUNSHI BIO (01877) 38.65 -3.98
JXR (01951) 10.20 +0.99
BRII-B (02137) 19.36 -23.78
WUXI BIO (02269) 93.75 -8.00
CANSINOBIO-B (06185) 161.90 -15.85
ZHAOKE OPHTH-B (06622) 7.08 -0.14
AKESO-B (09926) 38.70 -1.28
KINTOR PHARMA-B (09939) 35.55 -10.90
-----------------------------------------------
(ed)